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The synthesis of 3-hydroxy-2,4,8-trimethyldec-
8-enolides and an approach to 3,4-dihydroxy-
2,4,6,8-tetramethyldec-8-enolide†
J. M. Botubol-Ares,a M. J. Durán-Peña,a A. J. Macías-Sánchez,a J. R. Hanson,b
I. G. Colladoa and R. Hernández-Galán*a
The synthesis of several derivatives of 3-hydroxy-2,4,8-trimethyldec-8-enolide and attempts at the
synthesis of 3,4-dihydroxy-2,4,6,8-tetramethyldec-8-enolide (1), a structure which has been assigned to
a metabolite of the phytopathogenic fungus, Botrytis cinerea, gave products whose spectroscopic data
had significant differences from those reported for the natural product 1. The rare 11-membered lactone
rings were constructed by ring-closing metathesis reactions. The increase in conformational restrictions
imposed by the substituents has a high influence on the stereochemistry of the ring-closing metathesis
reaction and gives rise to a decrease in the yield for the synthesis of 11-membered lactones. The pre-
dominant alkene which was obtained was the (Z)-isomer. The observed spectroscopic differences
between the synthesized lactones and the natural product and the spectroscopic data of its acetylated
derivative 26a allowed us to revise the structure 1 to that of the γ-butyrolactone 26.
Introduction
Botrytis cinerea is an aggressive phytopathogenic fungus that
affects more than 200 plant species1 producing a grey powdery
mould on the plants. The major phytotoxic metabolites of
B. cinerea are a family of sesquiterpenes with the botryane skel-
eton2 and two families of polyketide lactones with a common
biosynthetic origin. These are the botrylactones, and the
botcinic and botcineric acids with their cyclic relatives, the
botcinins.3
The structure, 3,4-dihydroxy-2,4,6,8-tetramethyldec-8-enolide
(1), has been assigned to a metabolite which was isolated from
a mutant strain of B. cinerea. This structure (Fig. 1) was
assigned on the basis of NMR data using COSY, HSQC, HMBC
and nOe-1D experiments.4 However there are only a few
examples of naturally occurring 11-membered lactones5
and the relative thermodynamic instability of 11-membered
lactones has made their synthesis and that of their derivatives
difficult even using Mitsunobu lactonization6 or an intramole-
cular Reformatsky reaction.7 Compound 1 was isolated in a
very small amount so its possible biological activity could not
be determined. In the context of our interest in the metab-
olites of B. cinerea, we have attempted to verify the structure 1
by means of a total synthesis which would not only provide
information about the chemistry of this interesting family but
also allow us to study its biological activity. Recently we have
carried out the enantioselective synthesis of 3,8 a close ana-
logue of the structure assigned to the natural product. We
examined the use of a ‘mutasynthetic’ biotransformation in
order to achieve the chemo- and stereoselective functionali-
zation of C-4. However no such functionalization was detected
and so we have resorted to chemical methods to achieve
this target. In this paper we describe the synthesis of several
3-hydroxy-2,4,8-trimethyldec-8-enolides and an approach to the
synthesis of the reported structure 1 for the natural product.
Results and discussion
We examined the synthesis of the analogous simpler lactone 2
with the aim of establishing a route to the introduction of the
Fig. 1 Structure of compound 1.
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functionality at the C-4 position. The retrosynthetic analysis of
2 is shown in Scheme 1 in which a ring-closing metathesis
(RCM) and an aldol condensation play key roles.
The ester 4 was prepared using our previously described
procedure.8 Stereoselective epoxidation with VO(acac)2 and
1.3 eq. of TBHP at −20 °C9 afforded the erythro epoxide 6
(Scheme 2). In addition the γ-butyrolactone 7 was obtained
when the reaction was performed at room temperature and
2.0 eq. of THBP were used. The RCM of 6 led to a Z/E mixture
of the lactones 8 in low yield and in which the Z isomer pre-
dominated. Alternatively the RCM of the ester 4 afforded the
lactone (E)-3 in 68% yield as a 9 : 1 E/Z mixture.
Epoxidation with VO(acac)2 and TBHP afforded the lactone
(E)-8. However the reductive cleavage of the epoxide was un-
successful under all the conditions that were examined.
At this stage we decided to adopt an alternative synthetic
route in which the 4-position was functionalized previously to
the RCM. With this aim, we chose compound 9a as a model
because it has the anti disposition between both C-3 and
C-4 hydroxyl groups found in compound 1. Furthermore it
could be synthesized in good yield through a syn aldol reaction
of the aldehyde 11a, obtained from the known alcohol 12a, fol-
lowed by exocyclic cleavage of the corresponding oxazolidinone
with allyl alcohol and RCM of the obtained ester 10a
(Scheme 3). In addition to the preparation of the compound
9a was achieved as a part of our ongoing program in increasing
the structural diversity of the 11-membered lactone by RCM.8
The synthesis of 9a began (Scheme 4) with a Sharpless
asymmetric epoxidation of the alcohol 12a with (+)-DIT10
which afforded the epoxide 13a in 90% yield. Reductive
cleavage of 13a with LiAlH4 gave the diol 14a whose sequential
protection of primary and tertiary hydroxyl groups with TBS
and MOM respectively, followed by desilylation and Swern oxi-
dation under mild conditions, afforded the aldehyde 11a
in good overall yield.
The aldehyde 11a was treated (Scheme 5) with an appropri-
ate oxazolidinone by the procedure reported by Evans11 to
afford the syn-aldol product 19a in 61% yield and 94% de. Exo-
cyclic cleavage of the oxazolidinone 19a with allyl alcohol and
4 eq. of allylmagnesium bromide at −20 °C generated the ester
10a with a yield of 68%. Finally a RCM reaction of 10a under
high dilution conditions catalyzed by the second generation
ruthenium complex A12 in dry, degassed, refluxing dichloro-
methane produced the 11-membered lactone 20a in only 18%
yield. However lactone 20a was obtained in 54% yield when
the reaction was carried out in the presence of a catalytic
amount of Ti(i-OPr)4.
13 In this occasion only Z isomer could
Scheme 2 Synthesis of lactones 3 and 8.
Scheme 4 Stereoselective synthesis of aldehyde 11a.
Scheme 1 Retrosynthetic analysis of lactone 2.
Scheme 3 Retrosynthetic analysis of 9a.
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be detected showing again a high influence of the nature of
substituents on C-4 and C-5 in the stereochemistry of the RCM
reaction.
Given that the geometry of the alkene obtained by RCM
could not be easily predicted, we decided to try the total
synthesis of 1 following a similar synthetic strategy to that
described in Scheme 3. Firstly we performed the enantio-
selective alkylation of the oxazolidinone (−)-(R)-18 with
3-bromo-2-methylprop-1-ene which proceeded as described in
the literature,14 to give the adduct 21. This had the required
stereochemistry of the methyl group at C6 of 1. Reductive clea-
vage of the auxiliary with NaBH4 gave the alcohol 22 in 90%
yield. A one-pot oxidation/olefination using the TEMPO-BAIB
system followed by reaction with (carbethoxyethylidene)-
triphenyl phosphorane15 produced the ester (E)-23 stereoselec-
tively and in 51% yield.‡ Reduction of (E)-23 with DIBALH and
subsequent Sharpless asymmetric epoxidation with (−)-DIT
afforded the epoxide 13b in 85% yield and 86% de (Scheme 6).
Conversion of this compound into aldehyde 11b was carried
out following a similar synthetic strategy that is described in
Scheme 4.
Condensation of the aldehyde 11b with the appropriate
oxazolidinone (Scheme 7) by the procedure reported by
Evans16 afforded via methanolysis of the silyloxy derivative the
anti-aldol product 19b in 58% yield and 94% de. Unexpectedly
the conversion of 19b into the ester 10b with allyl alcohol/
allylmagnesium bromide at 0 °C only proceeded with a 23%
yield. Attempts to improve this yield by varying the tempera-
ture and reagent stoichiometry or using SmI2
17 were un-
successful. Finally a RCM reaction catalyzed by the ruthenium
complex A in refluxing CH2Cl2 in the presence of a catalytic
amount of Ti(i-OPr)4,
13 afforded a complex mixture from
which the lactone 20b was isolated in only 15% yield. This
lactone was the (Z)-isomer, protected as its MOM ether, of the
target structure 1.
Unfortunately, all attempts to remove the MOM protecting
group from both compounds 20a and b were fruitless. So,
several attempts at the deprotection were carried out using
BF3·Et2O/DMS at different temperatures. This method has
been successfully used by Marco et al. for the removal of
a MOM protecting group in the last step of the synthesis of
stagnolide G, a 10-membered lactone with a free hydroxyl
group at the C-4 position.18 However we only obtained an
untreatable reaction mixture. Additional deprotection experi-
ments with ZnBr2–PrSH
19 again yielded a complex reaction
mixture.
The NMR data for all synthetic lactones (3, 8 and 20a–b)
together with those obtained in the previous mutasynthetic
experiments,8 when compared with those that had been
Scheme 5 Stereoselective synthesis of (Z)-20a.
Scheme 7 Stereoselective synthesis of (Z)-20a.
Scheme 6 Stereoselective synthesis of aldehyde 11b.
‡Z-isomer could not detected by 1H NMR.
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reported for the natural product 1, showed significant differ-
ences in the features that were common to all of them. Firstly
the proton signals which were assigned to H-10 in the natural
product appeared within a narrow range of chemical shifts
between δH 4.17 and δH 4.12 ppm typical of a freely rotating
system. In both the (Z)- and (E)-isomers of the synthetic
lactones, these proton resonances are clearly distinct, one of
them appearing at a higher chemical shift (δH 4.66–5.07 ppm)
(Table 1). Furthermore the synthetic lactones showed a corre-
lation in the HMBC experiment between the carbonyl of the
lactone and the H-10 signals which was not observed in the
corresponding experiment for the natural product. All
the differences revealed by the NMR data point to a possible
error in the structure assigned to the natural product. Con-
sequently the proposed 11-membered ring structure for 1 is
doubtful and a re-examination of this structure 1 was
necessary.
In the course of our research work with the phytopathogen
fungus B. cinerea, we studied the mutant bcbot4,20 which over-
produced polyketide metabolites, yielding a sufficient amount
of compounds 1, to revise the structure. The carbon framework
of 1 was unequivocally established on the basis of HSQC and
HMBC heteronuclear correlations. However in the light of our
synthetic work with the compounds 3, (Z)-8, (E)-8, 20a and
20b, a significant observation was the absence of a three-bond
through-oxygen HMBC correlation for the OvC–O–C–H
system in the natural product 1. This led us to consider an
alternative γ-butyrolactone structure 26 for the natural product
(Fig. 2). The γ-butyrolactone would be thermodynamically
more stable than the 11-membered lactone. In the literature
there are a number of precedents for the corrections21,22 to the
structures of medium-sized lactones.
Acetylation of 26, under standard conditions, quantitatively
afforded a diacetate 26a whose NMR spectra showed the in-
corporation of two acetate units. The resonances assigned
to H-10 had shifted from δH 4.12 and 4.17 ppm in 26 to δH
4.58 ppm in 26a. This signal was correlated in the HMBC with
the signal assigned to the carbonyl group of the acetate at δC
170.1 ppm indicating that an acetyl group was on the hydroxyl
group on C-10 what is incompatible with the original structure
1. The other acetate group was situated on the hydroxyl group
on C-3 for the HMBC correlations observed between the
signals at δH 4.97 ppm (H-3) and the signal at δC 169.2 ppm.
The IR spectrum of the diacetate 26a had carbonyl absorption
at 1775 and 1740 cm−1 corresponding to the presence of
a γ-butyrolactone and acetate esters. Although compound 1
itself had IR absorption at 1748 cm−1 which is rather low for a
γ-butyrolactone, this might be affected by hydrogen bonding
from the hydroxyl group at C-3.23
The nOe observed interaction between H-2, H-3 and methyl
at C-4 supported a relative configuration of the ring as
2R*,3S*,4S*.
Conclusions
In summary we have examined several strategies for the
enantioselective synthesis of structures that are analogues of
that reported for the fungal metabolite 1 using the ring-
closing metathesis as a key-step. These included the (Z)-isomer
20b containing a MOM protecting group, and four compounds
3, (Z)-8, (E)-8 and 20a. The results showed that the increase in
conformational restrictions imposed by the substituents has
a high influence on the stereochemistry of the ring-closing
metathesis reaction and gives rise to a decrease in the yield for
the synthesis of 11-membered lactones. The predominant
alkene obtained was the (Z)-isomer. The observed spectro-
scopic differences between the synthetized lactones 3, (Z)-8,
(E)-8, 20a and 20b and the natural product 1 and spectroscopic
data of its acetylated derivative 26a allowed us to revise the
structure 1 to that of 4-hydroxy-5-(6-hydroxy-2,4-dimethylhex-
4-enyl)-3,5-dimethyl-4,5-dihydrofuran-2(3H)-one (26). Work is
in progress in order to determine its absolute configuration.
Experimental
General procedures
Unless otherwise noted, materials and reagents were obtained
from commercial suppliers and were used without further
purification. Dichloromethane, ethyl acetate and triethylamine
were freshly distilled from CaH2 and tetrahydrofuran was dried
over sodium and benzophenone and freshly distilled before
use. Air- and moisture-sensitive reactions were performed
under an argon atmosphere. Purification by semipreparative
and analytical HPLC was performed with Hitachi/Merck
L-6270 apparatus equipped with a differential refractometer
detector (RI-7490). A LiChrospher® Si 60 (5 µm) LiChroCart®
(250 mm × 4 mm) column and a LiChrospher® Si 60 (10 µm)
LiChroCart® (250 mm × 10 mm) were used in isolation experi-
ments. Silica gel (Merck) was used for column chromato-
graphy. TLC was performed on Merck Kiesegel 60 F254,
0.25 mm thick. Optical rotations were determined with a
digital polarimeter. Infrared spectra were recorded on a FT-IR
spectrophotometer and reported as wavenumber (cm−1).
1H and 13C NMR measurements were recorded on Varian
Unity 400 MHz, Agilent 500 MHz and Varian Inova 600 MHz
Fig. 2 Compounds 26 and 26a.
Table 1 Comparison of δH of H-10 and H-10’ protons for compounds
1, 3, (Z)-8, (E)-8 and 20a–b (δH values in ppm)
Comp./position 1 3 (Z)-8 (E)-8 20a 20b
H-10 4.12 4.33 4.29 4.42 4.33 4.12
H-10′ 4.17 4.68 4.80 4.66 4.75 5.07
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spectrometers with SiMe4 as the internal reference. Chemical
shifts are reported in parts per million (ppm) and were refer-
enced to CDCl3 (δH 7.25, δC 77.0). NMR assignments were
made using a combination of 1D and 2D techniques. Multipli-
cities are described using the following abbreviations: s =
singlet, d = doublet, t = triplet, q = quarter; quint = quintuplet;
sext = sextuplet; m = multiplet, br = broad. High-Resolution
Mass Spectra (HRMS) was recorded with a double-focusing
magnetic sector mass spectrometer in the positive ion mode
or with a QTOF mass spectrometer in positive ion electrospray
mode at 20 V cone voltage or in positive ion APCI mode.
Synthesis of the substrates
(2R,3R,4E)-Allyl 3-hydroxy-2,4,8-trimethylnona-4,8-dienoate
(4). This compound was obtained by means of the procedure
described in the literature and its spectroscopic data were
identical to those described in the literature.8
(2R,3R,4S,5R)-Allyl 4,5-epoxy-3-hydroxy-2,4,8-trimethyl-non-
8-enoate (6). VO(acac)2 (vanadyl acetylacetonate, 17.9 mg,
0.06 mmol) was added to a solution cooled at −20 °C of
(2R,3R,4E)-allyl 3-hydroxy-2,4,8-trimethylnona-4,8-dienoate (4)
(180.0 mg, 0.71 mmol) in dry CH2Cl2 (1.8 mL) under an argon
atmosphere. The mixture was stirred for 10 min and then
TBHP (0.18 mL of a solution 5.0–6.0 M in nonane, 0.93 mmol)
was added. The mixture was stirred for 3 h and a saturated
solution of Na2SO3 (3 mL) was added and then allowed to
warm to room temperature with stirring for 30 min. The
aqueous layer was extracted three times with diethyl ether
(15 mL) and the organic layer was washed with brine, dried
over anhydrous sodium sulphate and filtered. Evaporation of
the solvent gave a crude product that was purified by silica gel
column chromatography. Elution with petroleum ether–Et2O
(75 : 25) yielded the compound 6 as a single isomer (123.3 mg,
64%). Colourless oil; [α]20D +17.5° (c 0.65 in CHCl3); IR (film)
νmax/cm
−1 3480 (OH), 3079, 2940, 1739 (CO), 1650, 1456, 1376,
1246, 1186, 1041, 996, 889; 1H NMR (400 MHz, CDCl3) δH 5.92
(1H, ddt, J 17.2, 10.6, 5.6 Hz, 2′-H), 5.32 (1H, ddd, J 17.2, 2.8,
1.4 Hz, 3′a-H), 5.23 (1H, ddd, J 10.6, 2.8, 1.4 Hz, 3′b-H), 4.74
(br s, 1H, 9a-H), 4.71 (br s, 1H, 9b-H), 4.61 (2H, d, J 5.6 Hz,
1′-H), 4.11 (1H, d, J 4.0 Hz, 3-H), 3.11 (1H, t, J 6.2 Hz, 5-H),
2.68 (1H, dq, J 7.2, 4.0 Hz, 2-H), 2.28 (OH, s), 2.16 (2H, m,
7-H), 1.73 (3H, s, 8-Me), 1.70 (2H, m, 6-H), 1.29 (3H, s, 4-Me),
1.15 (3H, d, J 7.2 Hz, 2-Me); 13C NMR (100 MHz, CDCl3)
δC 173.8, 144.5, 132.0, 118.3, 110.5, 72.7, 65.4, 61.3, 58.8, 41.5,
34.3, 26.3, 22.4, 14.8, 10.2; HRMS (CI+): calcd for C15H25O4
[M + H]+ 269.1753, found 269.1745.
(2R,3R,4R,5R,1′R)-4-Hydroxy-5-(1-hydroxy-4-methylpent-4-enyl)-
3,5-dimethyl-4,5-dihydrofuran-2(3H)-one (7). VO(acac)2 (vanadyl
acetylacetonate, 5.0 mg, 0.02 mmol) was added to a solution of
(2R,3R,4E)-allyl 3-hydroxy-2,4,8-trimethylnona-4,8-dienoate (4)
(50.0 mg, 0.2 mmol) in dry CH2Cl2 (0.3 mL) under an argon
atmosphere at room temperature. The mixture was stirred for
10 min before the addition of TBHP (0.07 mL of a solution
5.0–6.0 M in nonane, 0.4 mmol). The mixture was stirred for
18 h and then quenched with a saturated solution of Na2SO3
(1 mL) and was stirred for an additional 30 min. The aqueous
layer was extracted three times with diethyl ether (10 mL) and
the organic layer was washed with brine, dried over anhydrous
sodium sulphate and filtered. Evaporation of the solvent gave
a crude product that was purified by silica gel column
chromatography. Elution with petroleum ether–Et2O (70 : 30)
yielded the compound 7 (19.0 mg, 45%). Colourless oil;
[α]20D +13.7° (c 1.8 in CHCl3); IR (film) νmax/cm
−1 3412 (OH),
3075, 2934, 1780 (CO), 1455, 1380, 1217, 1096, 1047, 949, 887;
1H NMR (500 MHz, CDCl3) δH 4.76 (1H, br s, 5′a-H), 4.74 (1H,
br s, 5′b-H), 3.97 (1H, dd, J 6.8, 5.5 Hz, 4-H), 3.95 (1H, dd,
J 10.5, 3.8, 2.0 Hz, 1′-H), 3.36 (OH, d, J 5.5 Hz), 2.85 (OH, d,
J 3.8 Hz), 2.77 (1H, q, J 6.8 Hz, 3-H), 2.26 (1H, ddd, J 14.4, 8.8,
6.2 Hz, 3′a-H), 2.12 (1H, dt, J 14.4, 7.6 Hz, 3′b-H), 1.85 (1H,
dddd, J 14.1, 8.8, 7.6, 2.0 Hz, 2′a-H), 1.74 (3H, s, 4′-Me), 1.69
(1H, dddd, J 14.1, 10.5, 7.6, 6.2 Hz, 2′b-H), 1.43 (3H, s, 5-Me),
1.35 (3H, d, J 6.8 Hz, 3-Me); 13C NMR (125 MHz, CDCl3)
δC 176.6, 145.5, 111.0, 85.3, 82.9, 73.7, 43.6, 34.5, 28.6, 22.3,
20.3, 14.2; HRMS (CI+): calcd for C12H18O3 [M − H2O]+
210.1256, found 210.1266.
RCM of ester 6. (1,3-Bis(2,4,6-trimethylphenyl)-2-imidazoli-
dinylidene)dichloro(phenylmethylene)tricyclohexylphosphine)
ruthenium (2nd generation Grubbs ruthenium catalyst,
93.7 mg, 0.11 mmol) was added to a refluxing stirred solution
of ester 6 (101.0 mg, 0.38 mmol) in deoxygenated and dry
CH2Cl2 (316 mL) under an argon atmosphere. The reaction
mixture was stirred until consumption of the starting material
(18 h). The crude product was filtered over a pad of silica gel,
and washed with ethyl acetate (400 mL). The solvent was
removed under reduced pressure to give a crude product that
was purified by silica gel column chromatography. Elution
with ether petroleum–Et2O (90 : 10) yielded a mixture 3 : 1 of
(Z)-8 (23.8 mg, 26%) and (E)-8 (7.9 mg, 8%).§
(2R,3R,4S,5R,8Z)-4,5-Epoxy-3-hydroxy-2,4,8-trimethyldec-8-
enolide (Z)-(8). Colourless oil; [α]20D −14.9° (c 0.77 in CHCl3);
IR (film) νmax/cm
−1 3434 (OH), 2928, 1737 (CO), 1456, 1383,
1205, 1081, 935, 904; 1H NMR (500 MHz, CDCl3) δH 5.73 (1H,
dt, J 7.0, 1.2 Hz, 9-H), 4.80 (1H, dd, J 12.0, 7.0 Hz, 10a-H), 4.29
(1H, dd, J 12.0, 7.0 Hz, 10b-H), 3.70 (1H, d, J 4.4 Hz, 3-H), 3.08
(1H, dd, J 11.2, 2.8 Hz, 5-H), 2.71 (1H, dq, J 7.2, 4.4 Hz, 2-H),
2.38–2.30 (1H, m, 7a-H), 2.22–2.16 (1H, m, 7b-H), 1.77 (3H, s,
8-Me), 1.48–1.39 (2H, m, 6-H), 1.32 (3H, s, 4-Me), 1.31 (3H, d, J
7.2 Hz, 2-Me); 13C NMR (125 MHz, CDCl3) δC 172.8, 143.8,
120.9, 75.4, 62.3, 59.4, 59.1, 44.3, 28.2, 23.9, 22.1, 16.7, 15.8;




enolide (E)-(8). Colourless oil; [α]20D +30.3° (c 0.1 in CHCl3); IR
(film) νmax/cm
−1 3430 (OH), 2929, 1735 (CO), 1456, 1384, 1205,
1083, 997, 941; 1H NMR (500 MHz, CDCl3) δH 5.79 (1H, dd,
J 8.8, 6.6 Hz, 9-H), 4.66 (1H, dd, J 10.9, 6.6 Hz, 10a-H), 4.42
(1H, dd, J 10.9, 8.8 Hz, 10b-H), 3.01 (1H, d, J 10.5 Hz, 3-H),
2.69 (1H, dd, J 10.6, 1.7 Hz, 5-H), 2.53 (1H, dq, J 10.5, 6.6 Hz,
2-H), 2.26–2.18 (1H, m, 7a-H), 1.99 (1H, ddd, J 14.5, 4.2,
§50% based on the reacted material.
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1.6 Hz, 7b-H), 1.77 (3H, d, J 1.6 Hz, 8-Me), 1.63–1.54 (2H, m,
6-H), 1.30 (3H, s, 4-Me), 1.24 (3H, d, J 6.6 Hz, 2-Me); 13C NMR
(125 MHz, CDCl3) δC 174.5, 143.8, 121.6, 80.4, 64.7, 64.4, 60.8,
42.0, 36.2, 25.6, 15.9, 14.4, 10.9; HRMS (CI+): calcd for
C13H21O4 [M + H]
+ 241.1440, found 241.1444.
RCM of ester 4. Ester 4 (36.0 mg, 0.14 mmol) was converted
to an inseparable mixture 9 : 1 of (E)-3 (19.5 mg, 61%) and
(Z)-3 (2.1 mg, 7%) following the methodology described above
for the RCM of ester 6. Spectroscopic data of both compounds
were identical to those described in the literature.8
Epoxidation of lactone (E)-3. (2R,3R,4E,8E)-3-hydroxy-2,4,8-tri-
methyldeca-4,8-dienolide ((E)-3) (13.0 mg, 0.06 mmol) was con-
verted to a single product, whose spectroscopic data were
identical to those described for (E)-8 (12.0 mg, 86%), following the
methodology described above for the epoxidation of the ester 4.
(E)-2,6-Dimethylhepta-2,6-dien-1-ol (12a). This compound
was obtained by means of the procedure described in the
literature and its spectroscopic data were identical to those
described in the literature.8
(2S,3S)-2,3-Epoxy-2,6-dimethylhept-6-en-1-ol (13a). Ti(i-OPr)4
(4.3 mL, 14.7 mmol) was added at −20 °C to a solution of
(+)-DIT ((+)-diisopropyl L-tartrate, 3.8 mL, 17.7 mmol) in dry
CH2Cl2 (113 mL) under an argon atmosphere. The mixture was
stirred for 20 min, and then a solution of (E)-2,6-dimethyl-
hepta-2,6-dien-1-ol (12a) (2756 mg, 19.7 mmol) in dry CH2Cl2
(45 mL) was added slowly with stirring for 20 min. Finally,
TBHP (7.1 mL of a solution 5.0–6.0 M in nonane, 39.4 mmol)
was added slowly. When TLC showed that the reaction was
complete (3 h), diethyl ether (15 mL) and a saturated Na2SO4
solution (15 mL) were added and the mixture was allowed to
warm to room temperature, stirred for an additional hour,
filtered with Et2O through Celite and the solvent evaporated.
The crude was redissolved in diethyl ether (40 mL) and a solu-
tion of NaOH (1.25 g) in 40 mL of brine was added at 0 °C. The
mixture was stirred vigorously for 2 h and the aqueous layer
was separated and extracted with three portions of diethyl
ether (40 mL). The combined organic solution was washed
with brine (80 mL), dried over anhydrous sodium sulphate and
filtered. Evaporation of the solvent gave a crude product that
was purified by silica gel column chromatography. Elution
with petroleum ether–Et2O 80 : 20 yielded the alcohol 13a
(2778 mg, 90%). Colourless oil; [α]20D −6.4° (c 0.65 in CHCl3);
IR (film) νmax/cm
−1 3438 (OH), 3052, 2939, 1650, 1452, 1369,
1068, 1051, 892; 1H NMR (400 MHz, CDCl3) δH 4.75 (1H, br s,
7b-H), 4.72 (1H, br s, 7a-H), 3.67 (1H, dd, J 12.0, 4.6 Hz, 1b-H),
3.55 (1H, dd, J 12.0, 8.4 Hz, 1a-H), 3.04 (1H, t, J 6.2 Hz, 3-H),
2.22 (dd, J 8.4, 4.6 Hz, OH), 2.19 (1H, dd, J 14.4, 7.2 Hz, 5b-H),
2.11 (1H, dd, J 14.4, 7.6 Hz, 5a-H), 1.74 (3H, s, 6-Me), 1.73–1.70
(2H, m, 4-H), 1.29 (3H, s, 2-Me); 13C NMR (100 MHz, CDCl3) δC
144.6, 110.5, 65.4, 61.1, 59.8, 34.4, 26.3, 22.3, 14.1; HRMS
(CI+): calcd for C9H17O2 [M + H]
+ 157.1229, found 157.1230.
(R)-2,6-Dimethylhept-6-ene-1,2-diol (14a). LiAlH4 (31.9 mL
of a 1.0 M solution in Et2O, 31.9 mmol) was added slowly at
0 °C to a solution of (2S,3S)-2,3-epoxy-2,6-dimethylhept-6-en-1-
ol (13a) (2264 mg, 14.5 mmol) in THF (92 mL) under an argon
atmosphere. The mixture was allowed to warm to room temp-
erature and when TLC showed that the reaction was complete
(3 h), the mixture was re-cooled at 0 °C and water (20 mL) and
1 N HCl were added slowly until pH 3. The layers were separ-
ated and the aqueous layer was extracted with two portions of
ethyl acetate (40 mL). The combined organic solution was
washed with brine (80 mL), dried over anhydrous sodium sul-
phate, filtered and the solvent was evaporated under reduced
pressure to give diol 14a (2000 mg, 87%) as a colourless oil,
which was used in the next step without further purification.
[α]20D +2.5° (c 4.7 in CHCl3); IR (film) νmax/cm
−1 3300 (OH),
3074, 2942, 1650, 1456, 1374, 1134, 1055, 886; 1H NMR
(400 MHz, CDCl3) δH 4.68 (1H, br s, 7b-H), 4.65 (1H, br s, 7a-
H), 3.44 (1H, d, J 10.8 Hz, 1b-H), 3.38 (1H, d, J 10.8 Hz, 1a-H),
2.00 (2H, t, J 6.8 Hz, 5-H), 1.69 (3H, s, 6-Me), 1.48–1.41 (4H, m,
3-H and 4-H), 1.14 (3H, s, 2-Me); 13C NMR (100 MHz, CDCl3)
δC 145.5, 110.0, 72.9, 69.7, 38.13, 38.10, 23.1, 22.2, 21.6; HRMS
(CI+): calcd for C9H16O [M − H2O]+ 140.1201, found 140.1208.
(R)-1-(tert-Butyldimethylsilyloxy)-2,6-dimethylhept-6-en-2-ol
(15a). A solution of tert-butylchlorodimethylsilane (517 mg,
3.36 mmol) in dry THF (1.8 mL) was added to a solution of
imidazole (1307 mg, 19.2 mmol) and (R)-2,6-dimethylhept-6-
ene-1,2-diol (14a). (379 mg, 2.4 mmol) in dry THF (3.4 mL) at
0 °C under an argon atmosphere. The mixture was allowed to
warm to room temperature and when TLC showed that the
reaction was complete (6 h) diethyl ether was added (20 mL).
The organic layer was washed three times with brine (80 mL),
dried over anhydrous sodium sulphate, filtered and the solvent
evaporated under reduced pressure. The crude product was
purified by silica gel column chromatography. Elution with
petroleum ether–Et2O 90 : 10 yielded compound 15a (406 mg,
64%). Colourless oil; [α]20D +2.3° (c 2.9 in CHCl3); IR (film) νmax/
cm−1 3460 (OH), 3074, 2930, 2857, 1651, 1463, 1374, 1254,
1093, 885, 775; 1H NMR (400 MHz, CDCl3) δH 4.63 (1H, br s,
7b-H), 4.61 (1H, br s, 7a-H), 3.36 (1H, d, J 9.4 Hz, 1b-H), 3.31
(1H, d, J 9.4 Hz, 1a-H), 1.95 (2H, t, J 7.2 Hz, 5-H), 1.65 (3H, s,
6-Me), 1.48–1.33 (4H, m, 3-H and 4-H), 1.05 (3H, s, 2-Me), 0.89
(9H, s, SiC(CH3)3), 0.05 (6H, s, Si(CH3)2);
13C NMR (100 MHz,
CDCl3) δC 145.7, 109.9, 72.2, 70.1, 38.3, 38.1, 25.8 (3C), 23.1,
22.3, 21.7, 18.2, −5.5 (2C); HRMS (CI+): calcd for C15H31O2Si
[M − H]+ 271.2093, found 271.2079.
(R)-1-(tert-Butyldimethylsilyloxy)-2-(methoxymethoxy)-2,6-
dimethylhept-6-ene (16a). Chloromethyl methyl ether
(MOMCl) (0.41 mL, 4.93 mmol) was added slowly to a stirred
mixture of (R)-1-(tert-butyldimethylsilyloxy)-2,6-dimethylhept-6-
en-2-ol (15a) (384 mg, 1.41 mmol), N,N′-diisopropylethylamine
(1.2 mL, 7.05 mmol), N,N′-dimethylaminepyridine (34 mg,
0.28 mmol) in dry CH2Cl2 (12 mL) at 0 °C under an argon
atmosphere and the mixture was allowed to warm to room
temperature with stirring for 16 h. Then, saturated ammonium
chloride solution (40 mL) and diethyl ether (50 mL) were
added, the layers were separated and the aqueous layer was
extracted twice with Et2O (50 mL). The combined organic solu-
tion was washed with 0.1 N HCl (80 mL), saturated sodium
bicarbonate (80 mL), twice with brine (80 mL), dried over anhy-
drous sodium sulphate and filtered. The solvent was evapor-
ated under reduced pressure to give compound 16a (427 mg,
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99%) as a yellow oil, which was used in the next step without
further purification. [α]20D −2.8° (c 0.32 in CHCl3); IR (film)
νmax/cm
−1 3073, 2930, 1649, 1463, 1374, 1255, 1146, 1104,
1040, 886, 837, 776; 1H NMR (400 MHz, CDCl3) δH 4.72 (1H, d,
J 7.2 Hz, CHHOMe), 4.70 (1H, d, J 7.2 Hz, CHHOMe), 4.66 (1H,
br s, 7b-H), 4.64 (1H, br s, 7a-H), 3.49 (1H, d, J 10.0 Hz, 1b-H),
3.43 (1H, d, J 10.0 Hz, 1a-H), 3.33 (3H, s, OMe), 1.97 (2H, dd,
J 7.6, 6.0 Hz, 5-H), 1.68 (3H, s, 6-Me), 1.48–1.42 (4H, m, 3-H
and 4-H), 1.16 (3H, s, 2-Me), 0.86 (9H, s, SiC(CH3)3), 0.01 (6H,
s, Si(CH3)2);
13C NMR (100 MHz, CDCl3) δC 145.8, 109.8, 91.2,
78.5, 68.4, 55.1, 38.2, 36.1, 25.8 (3C), 22.2, 21.3, 21.1, 18.1,
−5.6 (2C); HRMS (CI+): calcd for C11H25O3Si [M − C6H11]+
233.1573, found 233.1570.
(R)-2-(Methoxymethoxy)-2,6-dimethylhept-6-en-1-ol (17a).
Tetrabutylammonium fluoride (TBAF, 1.7 mL of a 1.0 M solu-
tion, 1.7 mmol) was added slowly to a stirred solution of (R)-
1-(tert-butyldimethylsilyloxy)-2-(methoxymethoxy)-2,6-dimethyl-
hept-6-ene (16a) (371 mg, 1.18 mmol) in dry tetrahydrofuran
(12 mL) under an argon atmosphere. When TLC showed that
the reaction was complete (3 h), the mixture was washed three
times with brine (6 mL), dried over anhydrous sodium sul-
phate and filtered. The solvent was evaporated under reduced
pressure to give a crude product which was purified by silica
gel column chromatography. Elution with petroleum ether–
Et2O 70 : 30 yielded the alcohol 17a (201 mg, 85%). Colourless
oil; [α]20D −2.9° (c 0.15 in CHCl3); IR (film) νmax/cm−1 3458
(OH), 2932, 1650, 1442, 1374, 1238, 1144, 1028, 888; 1H NMR
(400 MHz, CDCl3) δH 4.66 (1H, d, J 7.2 Hz, CHHOMe), 4.65
(1H, br s, 7b-H), 4.63 (1H, d, J 7.2 Hz, CHHOMe), 4.62 (1H, br
s, 7a-H), 3.41 (1H, dd, J 13.6, 6.8 Hz, 1b-H), 3.36 (3H, s, OMe),
3.31 (1H, dd, J 13.6, 6.8 Hz, 1a-H), 1.96 (2H, t, J 6.8 Hz, 5-H),
1.65 (3H, s, 6-Me), 1.54–1.36 (4H, m, 3-H and 4-H), 1.12 (3H, s,
2-Me); 13C NMR (100 MHz, CDCl3) δC 145.4, 110.0, 90.7, 79.3,
68.2, 55.3, 38.0, 35.6, 22.2, 21.2, 20.0; HRMS (CI+): calcd for
C11H22O3 [M]
+ 202.1569, found 202.1564.
(R)-2-(Methoxymethoxy)-2,6-dimethylhept-6-enal (11a). An-
hydrous dimethylsulfoxide (DMSO, 0.25 mL, 4.4 mmol) in dry
CH2Cl2 (3.4 mL) was added over 5 min dropwise to a solution
of freshly distilled oxalyl chloride (0.15 mL, 1.76 mmol) in dry
CH2Cl2 (5.1 mL) at – 60 °C in a bath of acetone/N2 under an
argon atmosphere. The resulting clear solution was stirred for
an additional 10 min, and then a solution of (R)-2-(methoxy-
methoxy)-2,6-dimethylhept-6-en-1-ol (17a) (178.3 mg,
0.88 mmol) in CH2Cl2 (3.4 mL) was added dropwise over
5 min. During this time the solution acquired a white appear-
ance and stirring was continued for an additional 30 min at
−60 °C. Then N,N′-diisopropylethylamine (1.5 mL, 8.8 mmol)
was added dropwise over 5 min and stirring was continued for
an additional 15 min. The reaction flask was removed from the
cold bath and allowed to warm gradually to room temperature
with stirring over 30 min. This was followed by the addition of
water (10 mL). The organic layer was separated, and the
aqueous layer was extracted three times with dichloromethane
(15 mL). The combined organic solution was washed with
0.1 N HCl (30 mL), saturated sodium bicarbonate (30 mL),
water (30 mL), twice with brine (30 mL), dried over anhydrous
sodium sulphate and filtered. The solvent was concentrated
under reduced pressure at 0 °C to yield quantitatively the alde-
hyde 11a (176 mg, 100%) as a yellow oil that was used immedi-
ately in the next step. [α]20D +1.6° (c 1.2 in CHCl3); IR (film)
νmax/cm
−1 3074, 2924, 1734 (CO), 1651, 1453, 1376, 1144, 1119,
1084, 1049, 918, 889; 1H NMR (400 MHz, CDCl3) δH 9.48 (1H,
s, 1-H), 4.71 (1H, d, J 7.2 Hz, CHHOMe), 4.66 (1H, br s, 7b-H),
4.62 (1H, br s, 7a-H), 4.61 (1H, d, J 7.2 Hz, CHHOMe), 3.35
(3H, s, OMe), 1.96 (2H, t, J 7.2 Hz, 5-H), 1.64 (3H, s, 6-Me),
1.62–1.39 (4H, m, 3a-H, 3b-H and 4-H), 1.24 (3H, s, 2-Me);
13C NMR (100 MHz, CDCl3) δC 203.5, 145.0, 110.4, 92.0, 82.2,
55.8, 37.8, 34.8, 22.2, 20.6, 17.6; HRMS (ESI+): calcd for
C11H22O4Na [M + H2O + Na]
+ 241.1410, found 241.1405.
(4R,2″R,3″R,4″R)-4-Benzyl-3-[3-hydroxy-4-(methoxy-methoxy)-
2,4,8-trimethylnon-8-enoyl]oxazolidin-2-one (19a). n-Dibutyl-
boron triflate (1.1 mL of a 1.0 M solution in CH2Cl2,
1.1 mmol) was added dropwise at 0 °C to a stirred solution
of (−)-(4R)-4-benzyl-3-propionyloxazolidin-2-one ((−)-(R)-18)
(206.1 m, 0.88 mmol) in dry CH2Cl2 (1.3 mL) under an argon
atmosphere. The mixture was stirred for 5 min and then
N,N′-diisopropylethylamine was added dropwise (0.2 mL,
1.2 mmol). After complete addition, the mixture was stirred at
0 °C for 15 min. The yellow solution was re-cooled to −78 °C
and a solution of (R)-2-(methoxymethoxy)-2,6-dimethylhept-
6-enal (11a) (176 mg, 0.88 mmol) was added dropwise in dry
CH2Cl2 (0.5 mL). The mixture was stirred at −78 °C and was
then allowed to warm to 0 °C and stirred for an additional
hour. The reaction was quenched with a mixture of phosphate
buffer (1 mL of a 1.0 M solution at pH 7) and MeOH (3 mL) at
0 °C and the mixture was stirred for 5 min. Finally, a solution
2.4 : 1 MeOH–H2O2 30% (3 mL) was added slowly at 0 °C and
was stirred for an additional hour. The solvent was concen-
trated under reduced pressure and the residue was redissolved
in diethyl ether. The aqueous layer was extracted three times
with diethyl ether (10 mL). Combined extracts were washed
with brine (20 mL), dried over anhydrous sodium sulphate,
and then filtered. The solvent was evaporated under reduced
pressure to give a crude product which was purified by silica
gel column chromatography. Elution with petroleum ether–
ethyl acetate (75 : 25) yielded compound 19a (115.3 mg, 61%,
94% de). Colourless oil; [α]20D −24.8° (c 6.1 in CHCl3); IR (film)
νmax/cm
−1 3505 (OH), 3064, 2937, 1743 (CO), 1694 (CO), 1455,
1350, 1210, 1106, 1028, 971, 920, 890; 1H NMR (400 MHz,
CDCl3) δH 7.28 (2H, m, Harom), 7.23 (1H, m, Harom), 7.19
(2H, m, Harom), 4.73 (1H, d, J 7.2 Hz, CHHOMe), 4.69 (1H, br
s, 9′b-H), 4.67 (1H, d, J 7.2 Hz, CHHOMe), 4.66–4.62 (2H, m,
4-H and 9′a-H), 4.18 (2H, m, 5-H), 4.11 (1H, quint, J 6.8 Hz,
2′-H), 3.97 (1H, t, J 6.8 Hz, 3′-H), 3.40 (3H, s, OMe), 3.28 (1H,
dd, J 13.2, 3.6 Hz, CHHPh), 3.21 (d, J 6.8 Hz, CHOH), 2.76 (1H,
dd, J = 13.2, 9.6 Hz, CHHPh), 2.00 (2H, t, J 7.2 Hz, 7′-H), 1.69
(3H, s, 8′-Me), 1.66–1.48 (2H, m, 5′-H), 1.47–1.35 (2H, m, 6′-H),
1.29 (3H, d, J 6.8 Hz, 2′-Me), 1.19 (3H, s, 4′-Me); 13C NMR
(100 MHz, CDCl3) δC 176.4, 152.9, 145.5, 135.2, 129.4, 128.9,
127.3, 110.1, 91.0, 81.4, 74.4, 66.0, 55.7, 55.5, 38.9, 38.1, 37.7,
35.6, 22.2, 21.7, 20.4, 13.5; HRMS (CI+): calcd for C24H36NO6
[M + H]+ 434.2543, found 434.2559.
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non-8-enoate (10a). Allylmagnesium bromide (0.3 mL of a
1.0 M solution in Et2O, 0.3 mmol) was added at 0 °C to the
alcohol (0.9 mL) under an argon atmosphere in a Schlenk
flask. The allylic mixture was stirred for 10 min and re-cooled
at – 20 °C. Then, a solution of 19a (63.2 mg, 0.15 mmol) in
allylic alcohol (0.2 mL) was slowly added. When TLC monitor-
ing indicated the completion of the reaction (3 h), a saturated
ammonium chloride solution (4 mL) was added and then the
reaction mixture was allowed to warm to room temperature.
The aqueous layer was extracted three times with diethyl ether
(10 mL). Combined extracts were washed with brine (20 mL),
dried over anhydrous sodium sulphate, filtered and the solvent
was concentrated under reduced pressure. The crude product
was purified by silica gel column chromatography. Elution
with petroleum ether–Et2O (90 : 10) yielded the ester 10a
(33.8 mg, 68%) as a colourless oil; [α]20D +8.0° (c 0.68 in CHCl3);
IR (film) νmax/cm
−1 3444 (OH), 2950, 1732 (CO), 1645, 1456,
1377, 1153, 1030, 919, 887; 1H NMR (400 MHz, CDCl3) δH 5.90
(1H, ddt, J 17.2, 10.4, 5.8 Hz, 2′-H), 5.31 (1H, ddd, J 17.2, 2.8,
1.4 Hz, 3′a-H), 5.22 (1H, ddd, J 10.4, 2.8, 1.4 Hz, 3′b-H), 4.70
(1H, d, J 7.2 Hz, CHHOMe), 4.69 (1H, br s, 9b-H), 4.66 (1H, d,
J 7.2 Hz, CHHOMe), 4.65 (1H, br s, 9a-H), 4.56 (2H, dt, J 5.8,
1.4 Hz, 1′-H), 3.89 (1H, t, J 7.0 Hz, 3-H), 3.37 (3H, s, OMe), 3.14
(d, J 7.0 Hz, OH), 2.70 (1H, quint, J 7.0 Hz, 2-H), 1.98 (2H, t,
J 6.8 Hz, 7-H), 1.68 (3H, s, 8-Me), 1.60–1.40 (4H, m, 5a-H, 5b-H
and 6-H), 1.25 (3H, d, J 7.0 Hz, 2-Me), 1.18 (3H, s, 4-Me); 13C
NMR (100 MHz, CDCl3) δC 175.7, 145.5, 132.0, 118.3, 110.1,
91.0, 81.6, 75.1, 65.2, 55.7, 41.1, 38.1, 35.7, 22.3, 21.5, 19.7,
13.6; HRMS (ESI+): calcd for C17H30O5Na [M + H]
+ 337.1985,
found 337.1990.
RCM of 10a. A solution of ester 10a (18.6 mg, 0.06 mmol)
and freshly distilled Ti(i-OPr)4 (6 µL, 0.02 mmol) in deoxyge-
nated and dry CH2Cl2 (60 mL) was refluxed for 2 h under
an argon atmosphere. Then, a solution of catalyst A (10.0 mg,
0.01 mmol) in deoxygenated and dry CH2Cl2 (60 mL)
was added to the mixture and the whole was refluxed for
24 h. The crude was filtered over a pad of silica gel, and
washed with ethyl acetate. The solvent was removed
under reduced pressure to give a crude that was purified
by silica gel column chromatography. Elution with ether
petroleum–ethyl acetate 90 : 10 yielded the lactone (Z)-20a
(9.2 mg, 54%).
(2R,3R,4R,8Z)-3-Hydroxy-4-(methoxymethoxy)-2,4,8-trimethyldec-
8-enolide ((Z)-20a). Colourless oil; [α]20D −27.7° (c 0.17 in
CHCl3); IR (film) νmax/cm
−1 3508 (OH), 2921, 2850, 1728 (CO),
1454, 1377, 1252, 1142, 1036, 914, 827; 1H NMR (500 MHz,
CDCl3) δH 5.54 (1H, t, J 6.2 Hz, 9-H), 4.75 (1H, dd, J 12.8,
6.2 Hz, 10b-H), 4.74 (1H, d, J 7.6 Hz, CHHOMe), 4.65 (1H, d,
J 7.6 Hz, CHHOMe), 4.33 (1H, dd, J 12.8, 6.2 Hz, 10a-H), 3.82
(1H, d, J 10.2 Hz, 3-H), 3.38 (3H, s, OMe), 2.46 (1H, dq, J 10.2,
6.8 Hz, 2-H), 2.33 (1H, ddd, J 13.4, 9.2, 7.2 Hz, 7b-H), 1.84–1.80
(1H, m, 7a-H), 1.75–1.72 (1H, m, 5b-H), 1.70 (3H, s, 8-Me),
1.69–1.60 (2H, m, 6a-H and 6b-H), 1.33 (3H, d, J 6.8 2-Me),
1.25 (1H, m, 5a-H), 1.21 (3H, s, 4-Me); 13C NMR (125 MHz,
CDCl3) δC 174.0, 146.2, 118.7, 90.6, 81.8, 74.4, 60.8, 55.8, 43.0,
33.2, 32.1, 23.8, 20.4, 18.1, 16.4; HRMS (CI+): calcd for C9H15O
139.1123, found 139.1122.
(4R,2″S)-4-Benzyl-3[2,4-dimethylpent-4-enoyl]oxazolidin-2-one
(21). LHMDS (lithium bis(trimethylsilyl)amide, 2.5 mL of
a 1.0 M solution in THF) was added slowly to a solution
of (4R)-4-benzyl-3-propionyloxazolidin-2-one ((R)-18) (500 mg,
2.14 mmol) in dry THF (2.5 mL) under an argon atmosphere at
– 78 °C in a bath of acetone/N2. The mixture was stirred for
10 min and then a solution of 3-bromo-2-methylpropene
(0.4 mL, 4.1 mmol) in dry THF (0.5 mL) was added and
stirred for 1 h. The reaction mixture was allowed to warm to
room temperature and was stirred for additional 3 h.
Saturated ammonium chloride solution (10 mL) and ethyl
acetate (15 mL) were added, the layers were separated and the
aqueous layer was extracted twice with ethyl acetate (15 mL).
The combined organic phase was washed with brine (25 mL),
dried over anhydrous sodium sulphate and filtered. The
solvent was evaporated under reduced pressure to obtain
a crude product which was purified by silica gel column
chromatography. Elution with petroleum ether–AcOEt (85 : 15)
yielded compound 21 as an only isomer (558 mg, 91%).
Spectroscopic data of compound 21 were identical to those
described in the literature for its enantiomer14b Colourless oil;
[α]20D −50.4° (c 0.1 in CH2Cl2).
(S)-2,4-Dimethylpent-4-en-1-ol (22). NaBH4 (489.5 mg,
12.9 mmol) was added at 0 °C to a stirred solution of (4R,2″S)-
4-benzyl-3-[2,4-dimethylpent-4-enoyl]oxazolidin-2-one (21)
(1000 mg, 3.23 mmol) in a mixture 4 : 1 THF–H2O (16.1 mL).
When TLC showed that the reaction was complete (24 h), 1 N
HCl was added until pH = 7. The layers were separated and the
aqueous layer was extracted with two portions of Et2O (15 mL).
The combined organic solution was washed with brine
(30 mL), dried over anhydrous sodium sulphate and filtered.
The solvent was evaporated under reduced pressure at 0 °C to
give a crude product which was purified by silica gel column
chromatography. Elution with petroleum ether–Et2O (65 : 35)
yielded the alcohol 22 (332 mg, 90%). Colourless oil;
[α]20D −4.8° (c 0.42 in CHCl3); IR (film) νmax/cm−1 3400 (OH),
3089, 2850, 1634, 719; 1H NMR (500 MHz, CDCl3) δH 4.75 (1H,
br s, 5a-H), 4.70 (1H, br s, 5b-H), 3.50 (1H, dd, J 10.6, 5.6 Hz,
1a-H), 3.44 (1H, dd, J 10.6, 5.6 Hz, 1b-H), 2.10 (1H, m, 3a-H),
1.89–1.82 (2H, m, 2-H and 3b-H), 1.72 (3H, s, 4-Me), 0.89
(3H, d, J 6.4 Hz, 2-Me); 13C NMR (125 MHz, CDCl3) δC 144.5,
111.7, 68.4, 42.4, 33.6, 22.2, 16.6; HRMS (CI+): calcd for
C7H15O [M + H]
+ 115.1123, found 115.1125.
(2E,4S)-Ethyl 2,4,6-trimethylhepta-2,6-dienoate (23). TEMPO
(462 mg, 2.9 mmol) and BAIB (10.3 g, 31.9 mmol) were added
at 0 °C to a solution of (S)-2,4-dimethylpent-4-en-1-ol (22)
(1653 mg, 14.5 mmol) in dry CH2Cl2 (32.2 mL) and the
mixture was stirred for 4 h. Then, (carbethoxyethylidene)tri-
phenylphosphorane (13.4 g, 36.2 mmol) was added and the
solution was stirred for further 12 h at room temperature. The
solvent was removed under reduced pressure and the residue
was purified by silica gel column chromatography. Elution
with petroleum ether–Et2O (97 : 3) yielded the ester (E)-23
(1455.0 mg, 51%). Yellow oil; [α]20D +21.8° (c 0.12 in CHCl3); IR
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−1 2963, 1710 (CO), 1682, 1446, 1367, 1252,
1202, 1120, 1075, 890, 749; 1H NMR (400 MHz, CDCl3) δH 6.54
(1H, dq, J = 10.0, 1.4 Hz, 3-H), 4.72 (1H, br s, 7a-H), 4.65 (1H,
br s, 7b-H), 4.16 (2H, q, J 7.2 Hz, 1′-H), 2.68 (1H, dsext, J 10.0,
6.8 Hz, 4-H), 2.03 (2H, d, J 6.8 Hz, 5-H), 1.83 (3H, d, J 1.4 Hz,
2-Me), 1.68 (3H, s, 6-Me), 1.27 (3H, t, J 7.2 Hz, 2′-H), 0.98 (3H,
d, J 6.8 Hz, 4-Me); 13C NMR (100 MHz, CDCl3) δC 168.4, 147.5,
143.4, 126.3, 112.0, 60.4, 44.9, 31.4, 22.3, 19.5, 14.3, 12.4;
HRMS (CI+): calcd for C10H15O [M − C2H5O]+ 151.1123, found
151.1122.
(2E,4S)-2,4,6-Trimethylhepta-2,6-dien-1-ol (12b). Diisobutyl-
aluminum hydride (DIBAL) (16.3 mL of a 1.0 M solution in
CH2Cl2, 16.3 mmol) was slowly added to a solution of (2E,4S)-
ethyl 2,4,6-trimethylhepta-2,6-dienoate (23) (1455.0 mg,
7.42 mmol) in dry CH2Cl2 (23.3 mL) and cooled at −78 °C.
When TLC showed that the reaction was complete (1 h), a satu-
rated solution of Rochelle’s salt (40 mL) was added and the
mixture was allowed to warm to room temperature while main-
taining vigorous stirring. The aqueous phase was extracted
with CH2Cl2 (3 × 50 mL) and the combined organic solutions
were washed, dried over anhydrous sodium sulphate and fil-
tered. Evaporation of the solvent rendered a crude product that
was purified by silica gel column chromatography. Elution
with petroleum ether–ethyl acetate (80 : 20) yielded (2E,4S)-
2,4,6-trimethylhepta-2,6-dien-1-ol (12b) (826.1 mg, 72%). Col-
ourless oil; [α]20D −6.0° (c 0.83 in CHCl3); IR (film) νmax/cm−1
3314 (OH), 3072, 2958, 1651, 1455, 1374, 1011, 885; 1H NMR
(400 MHz, CDCl3) δH 5.18 (1H, dq, J 9.2, 1.2 Hz, 3-H), 4.70 (1H,
br s, 7a-H), 4.62 (1H, br s, 7b-H), 3.98 (2H, br s, 1-H), 2.59 (1H,
dsext, J 9.2, 6.8 Hz, 4-H), 1.97 (2H, dd, J 6.8, 1.2 Hz, 5-H), 1.69
(3H, t, J 1.2 Hz, 6-Me), 1.67 (3H, d, J 1.2 Hz, 2-Me), 0.92 (3H, d,
J 6.8 Hz, 4-Me); 13C NMR (100 MHz, CDCl3) δC 144.2, 133.2,
132.1, 111.3, 68.6, 45.6, 30.0, 22.2, 20.3, 13.5; HRMS (CI+):
calcd for C10H17 [M + H − H2O]+ 137.1330, found 137.1315.
(2R,3R,4S)-2,3-Epoxy-2,4,6-trimethylhept-6-en-1-ol (13b). (2E,4S)-
2,4,6-trimethylhepta-2,6-dien-1-ol (12b) (826.1 mg, 5.36 mmol)
was converted to (2R,3R,4S)-2,3-epoxy-2,4,6-trimethylhept-6-en-
1-ol (13b) (773.9 mg, 85% yield, 86% de) following the
methodology described above for the Sharpless asymmetric
epoxidation of compound 12a. Orange oil; [α]20D +1.9° (c 0.88 in
CHCl3); IR (film) νmax/cm
−1 3418 (OH), 3074, 2927, 1646, 1455,
1378, 1070, 1035, 891; 1H NMR (400 MHz, CDCl3) δH 4.77 (1H,
br s, 7a-H), 4.68 (1H, br s, 7b-H), 3.64 (1H, dd, J 12.2, 4.6 Hz,
1a-H), 3.54 (1H, dd, J 12.2, 7.8 Hz, 1b-H), 2.73 (1H, d, J 9.4 Hz,
3-H), 2.03 (1H, ddd, J 13.2, 7.0, 0.8 Hz, 5a-H), 1.95 (1H, ddd,
J 13.2, 7.0, 0.8 Hz, 5b-H), 1.69 (3H, s, 6-Me), 1.63 (1H, dsext,
J 9.4, 7.0 Hz, 4-H), 1.26 (3H, s, 2-Me), 1.06 (3H, d, J 7.0 Hz,
4-Me); 13C NMR (100 MHz, CDCl3) δC 142.9, 112.3, 65.49,
65.46, 62.1, 42.3, 30.7, 22.3, 17.6, 14.5; HRMS (ESI+): calcd for
C10H18O2Na [M + Na]
+ 193.1204, found 193.1199.
(2S,4S)-2,4,6-Trimethylhept-6-ene-1,2-diol (14b). (2R,3R,4S)-
2,3-epoxy-2,4,6-trimethylhept-6-en-1-ol (13b) (773.9 mg,
4.55 mmol) was converted to (2S,4S)-2,4,6-trimethylhept-6-ene-
1,2-diol (14b) (675.3 mg, 86%) following the methodology
described above for the synthesis of 14a. Colourless oil;
[α]20D +4.2° (c 0.22 in CHCl3); IR (film) νmax/cm
−1 3378 (OH),
3073, 2928, 1649, 1458, 1376, 1038, 888; 1H NMR (500 MHz,
CDCl3) δH 4.74 (1H, br s, 7a-H), 4.64 (1H, br s, 7b-H), 3.42 (1H,
d, J 10.8 Hz, 1a-H), 3.35 (1H, d, J 10.8 Hz, 1b-H), 1.98 (1H, dd,
J 12.0, 5.6 Hz, 5a-H), 1.88–1.79 (2H, m, 5b-H and H-4),
1.68 (3H, s, 6-Me), 1.45 (1H, dd, J 14.4, 7.2 Hz, 3a-H), 1.28 (1H,
dd, J 14.4, 7.6 Hz, 3b-H), 1.17 (3H, s, 2-Me), 0.96 (3H, d, J
6.4 Hz, 4-Me); 13C NMR (125 MHz, CDCl3) δC 144.5, 111.9,
73.4, 70.5, 47.7, 44.7, 26.5, 23.3, 22.1, 21.8; HRMS (CI+): calcd
for C10H21O2 [M + H]
+ 173.1542, found 173.1542.
(2S,4S)-1-(tert-Butyldimethylsilyloxy)-2,4,6-trimethylhept-6-en-
2-ol (15b). (2S,4S)-2,4,6-trimethylhept-6-ene-1,2-diol (14b)
(675.3 mg, 3.92 mmol) was converted to (2S,4S)-1-(tert-butyldi-
methylsilyloxy)-2,4,6-trimethylhept-6-en-2-ol (15b) (1027.4 mg,
92%) following the methodology described above for the syn-
thesis of 15a. Colourless oil; [α]20D +3.8° (c 0.13 in CHCl3); IR
(film) νmax/cm
−1 3475 (OH), 3074, 2954, 2858, 1648, 1463,
1376, 1255, 1094, 836, 776; 1H NMR (400 MHz, CDCl3) δH 4.72
(1H, br s, 7a-H), 4.64 (1H, br s, 7b-H), 3.38 (1H, d, J 9.2 Hz,
1a-H), 3.33 (1H, d, J 9.2 Hz, 1b-H), 2.23 (OH, br s), 1.98 (1H, m,
5a-H), 1.88–1.79 (2H, m, 5b-H and 4-H), 1.68 (3H, s, 6-Me),
1.40 (1H, dd, J 14.4, 3.4 Hz, 3a-H), 1.26 (1H, dd, J 14.4, 7.6 Hz,
3b-H), 1.13 (3H, s, 2-Me), 0.98 (3H, d, J 6.0 Hz, 4-Me), 0.90 (9H,
s, SiC(CH3)3), 0.06 (6H, s, Si(CH3)2);
13C NMR (100 MHz,
CDCl3) δC 144.6, 111.7, 72.7, 70.9, 47.8, 44.6, 26.5, 25.9 (3C),
23.4, 22.1, 21.6, 18.3, −5.5 (2C); HRMS (CI+): calcd for
C16H35O2Si [M + H]
+ 287.2406, found 287.2397.
(2S,4S)-1-(tert-Butyldimethylsilyloxy)-2-(methoxymethoxy)-2,4,6-
trimethylhept-6-ene (16b). (2S,4S)-1-(tert-butyl-dimethylsilyloxy)-
2,4,6-trimethylhept-6-en-2-ol (15b) (486.8 mg, 1.70 mmol) was
converted to (2S,4S)-1-(tert-butyldimethylsilyloxy)-2-(methoxy-
methoxy)-2,4,6-trimethyl-hept-6-ene (16b) (506.0 mg, 90%)
following the methodology described above for the synthesis
of 16a. Colourless oil; [α]20D +4.4° (c 0.14 in CHCl3); IR (film)
νmax/cm
−1 3072, 2929, 1648, 1460, 1374, 1256, 1101, 1037, 837,
776; 1H NMR (400 MHz, CDCl3) δH 4.74 (1H, d, J 7.4 Hz,
CHHOMe), 4.73 (1H, br s, 7a-H), 4.71 (1H, d, J 7.4 Hz,
CHHOMe), 4.64 (1H, br s, 7b-H), 3.49 (1H, d, J 10.0 Hz, 1a-H),
3.46 (1H, d, J 10.0 Hz, 1b-H), 3.35 (3H, s, OMe), 2.07 (1H, dd,
J 17.2, 9.6 Hz, 5a-H), 1.85–1.79 (2H, m, 4-H and 5b-H), 1.68
(3H, s, 6-Me), 1.51 (1H, dd, J 14.6, 3.8 Hz, 3a-H), 1.35 (1H, dd,
J 14.6, 7.0 Hz, 3b-H), 1.20 (3H, s, 2-Me), 0.91 (3H, d, J 6.0 Hz,
4-Me), 0.88 (9H, s, SiC(CH3)3), 0.03 (6H, s, Si(CH3)2);
13C NMR
(100 MHz, CDCl3) δC 144.8, 111.6, 91.2, 79.1, 69.0, 55.3, 47.7,
42.8, 26.1, 25.8 (3C), 22.1, 21.4, 21.3, 18.2, −5.6 (2C); HRMS




trimethylhept-6-ene (16b) (506.8 mg, 1.53 mmol) was con-
verted to (2S,4S)-2-(methoxymethoxy)-2,4,6-trimethylhept-6-en-
1-ol (17b) (276.0 mg, 84%) following the methodology
described above for the synthesis of 17a. Colourless oil;
[α]20D +5.6° (c 0.33 in CHCl3); IR (film) νmax/cm
−1 3439 (OH),
2920, 1646, 1446, 1374, 1256, 1150, 1111, 1042, 886; 1H NMR
(400 MHz, CDCl3) δH 4.74 (1H, br s, 7a-H), 4.70 (1H, d,
J 7.4 Hz, CHHOMe), 4.68 (1H, d, J 7.4 Hz, CHHOMe), 4.64 (1H,
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br s, 7b-H), 3.46 (1H, dd, J 12.2, 6.2 Hz, 1a-H), 3.41 (3H, s,
OMe), 3.36 (1H, dd, J 12.2, 8.0 Hz, 1b-H), 3.26 (OH, dd, J 8.0,
6.2 Hz), 2.01 (1H, m, 5a-H), 1.88–1.80 (2H, m, 5b-H and 4-H),
1.68 (3H, t, J 1.2 Hz, 6-Me), 1.42 (1H, dd, J 14.4, 3.2 Hz, 3a-H),
1.38 (1H, dd, J 14.4, 7.6 Hz, 3b-H), 1.20 (3H, s, 2-Me), 0.91 (3H,
d, J 6.4 Hz, 4-Me); 13C NMR (100 MHz, CDCl3) δC 144.4, 111.9,
90.8, 80.0, 68.9, 55.4, 47.8, 42.2, 26.2, 22.1, 21.4, 20.3; HRMS
(CI+): calcd for C12H24O3 [M]
+ 216.1725, found 216.1734.
(2S,4S)-2-(Methoxymethoxy)-2,4,6-trimethylhept-6-enal (11b).
(2S,4S)-2-(Methoxymethoxy)-2,4,6-trimethylhept-6-en-1-ol (17b)
(260.0 mg, 1.20 mmol) was converted to (2S,4S)-2-(methoxy-
methoxy)-2,4,6-trimethylhept-6-enal (11b) (250.0 mg, 97%)
following the methodology described above for the synthesis
of 11a. Colourless oil; [α]20D −6.7° (c 0.17 in CHCl3); IR (film)
νmax/cm
−1 3072, 2929, 1735 (CO), 1648, 1457, 1376, 1145, 1032,
889; 1H NMR (400 MHz, CDCl3) δH 9.55 (1H, s, 1-H), 4.76
(1H, d, J 7.2 Hz, CHHOMe), 4.73 (1H, br s, 7a-H), 4.65 (1H, d,
J 7.2 Hz, CHHOMe), 4.63 (1H; br s, 7b-H), 3.38 (3H, s, OMe),
1.96 (1H, dd, J 15.6, 9.6 Hz, 5a-H), 1.87–1.82 (2H, m, 5b-H and
4-H), 1.65 (3H, s, 6-Me), 1.63 (1H, dd, J 14.6, 3.6 Hz, 3a-H),
1.46 (1H, dd, J 14.6, 8.2 Hz, 3b-H), 1.29 (3H, s, 2-Me), 0.86 (3H,
d, J 6.0 Hz, 4-Me); 13C NMR (100 MHz, CDCl3) δC 203.9, 143.9,
112.2, 91.9, 82.8, 55.7, 47.1, 42.5, 25.9, 22.0, 21.4, 18.6; HRMS





(4S)-4-Benzyl-3-propionyloxazolidin-2-one ((+)-(S)-18)) (244 mg,
1.05 mmol) was treated with MgCl2 (10.4 mg, 0.11 mmol),
NaSbF6 (84.8 mg, 0.33 mmol), triethylamine (0.25 mL,
2.1 mL), aldehyde 11b (260.0 mg, 1.21 mmol) and chloro-
trimethylsilane (0.18 mL, 1.58 mmol) in ethyl acetate (2.6 mL)
at 25 °C for 48 h. The orange slurry was pushed through a pad
of silica with Et2O (200 mL) and the solvent was removed under
reduced pressure. The residue was dissolved in dry methanol
(105 mL) and trifluoroacetic acid (0.1 mL, 1.30 mmol) was
added at 0 °C. The mixture was stirred for 15 minutes and the
solvent was evaporated under reduced pressure to obtain a
crude product which was purified by silica gel column chrom-
atography. Elution with petroleum ether–ethyl acetate (85 : 15)
yielded compound 19b (268.2 mg, 58%, 94% de). Colourless
oil: [α]20D +12.4° (c 0.66 in CHCl3); IR (film) νmax/cm
−1 3466
(OH), 2928, 1781 (CO), 1676 (CO), 1456, 1384, 1208, 1030, 918,
890; 1H NMR (400 MHz, CDCl3) δH 7.31–7.28 (2H, m, Harom),
7.25–7.20 (3H, m, Harom), 4.69 (1H, br s, 7′a-H), 4.68 (1H, d,
J 7.2 Hz, CHHOMe), 4.67 (1H, d, J 7.2 Hz, CHHOMe), 4.65–4.59
(2H, m, 4-H and 7′b-H), 4.36 (OH, d, J 9.4 Hz), 4.33 (1H, dq,
J 7.2, 2.4 Hz, 2′-H), 4.10 (2H, m, 5-H), 3.57 (1H, dd, J 9.4, 2.4
Hz, 3′-H), 3.42 (1H, dd, J 13.2, 2.8 Hz, CHHPh), 3.27 (3H, s,
OMe), 2.55 (1H, dd, J 13.2, 10.6 Hz, CHHPh), 2.08 (1H, dd,
J 12.0, 4.6 Hz, 7a′-H), 1.91 (1H, dd, J 13.6, 3.2 Hz, 5′a-H), 1.84
(1H, dd, J 12.0, 7.6 Hz, 7′b-H), 1.82–1.70 (1H, m, 6′-H), 1.66
(3H, s, 8′-Me), 1.38 (3H, d, J 7.2 Hz, 2′-Me), 1.35 (3H, s, 4′-Me),
1.33 (1H, dd, J 13.6, 6.5 Hz, 5′b-H), 0.90 (3H, d, J 6.4 Hz,
6′-Me); 13C NMR (100 MHz, CDCl3) δC 178.3, 152.9, 144.6,
135.5, 129.3, 129.0, 127.3, 111.7, 90.9, 81.8, 81.0, 65.8, 55.6,
55.3, 47.8, 43.1, 38.0, 34.6, 26.6, 22.0, 21.42, 21.37, 17.9; HRMS




tetramethylnon-8-enoate (10b). Compound 19b (31.0 mg,
0.07 mmol) was converted to (2R,3S,4S,6S)-allyl 3-hydroxy-4-
(methoxymethoxy)-2,4,6,8-tetramethylnon-8-enoate (10b)
(5.4 mg, 24%) following the methodology described above for
the synthesis of 10a. Colourless oil. [α]20D +2.6° (c 0.32 in
CHCl3); IR (film) νmax/cm
−1 3439 (OH), 2921, 1733 (CO), 1673,
1455, 1380, 1034, 746; 1H NMR (400 MHz, CDCl3) δH 5.91 (1H,
ddt, J 17.2, 10.4, 5.6 Hz, 2′-H), 5.33 (1H, ddd, J 17.2, 2.8,
1.6 Hz, 3′a-H), 5.24 (1H, ddd, J 10.4, 2.8, 1.6 Hz, 3′b-H),
4.73 (1H, br s, 9a-H), 4.67 (1H, d, J 7.2 Hz, CHHOMe), 4.64
(1H, d, J 7.2 Hz, CHHOMe), 4.63 (1H, br s, 9b-H), 4.56 (2H, m,
1′-H), 3.72 (OH, d, J 9.6 Hz), 3.46 (1H, dd, J 9.6, 2.8 Hz, 3-H),
3.32 (3H, s, OMe), 2.81 (1H, dq, J 7.2, 2.8 Hz, 2-H), 2.07 (1H,
dd, J 13.2, 5.2 Hz, 7a-H), 1.86–1.78 (2H, m, 5a-H and 7b-H),
1.77–1.72 (1H, m, 6-H), 1.68 (3H, s, 8-Me), 1.34 (3H, d, J
7.2 Hz, 2-Me), 1.29 (3H, s, 4-Me), 1.28–1.24 (1H, m, 5b-H), 0.89
(3H, d, J 6.0 Hz, 6-Me); 13C NMR (100 MHz, CDCl3) δC 176.2,
144.5, 132.0, 118.5, 111.8, 91.0, 81.4, 79.2, 65.1, 55.6, 47.8,
42.9, 38.7, 26.6, 22.1, 21.3, 20.7, 17.1; HRMS (ESI+): calcd for
C18H32O5Na [M + Na]
+ 351.2147, found 351.2142.
RCM of ester 10b. Compound 10b (8.2 mg, 8 µmol) was sub-
jected to an RCM following the methodology described above
for the synthesis of 10a. Elution with ether petroleum–EtOAc
(80 : 20) yielded a mixture of (Z)-20b (1.1 mg, 15%), 24 (2.2 mg,
28%) and 25 (3.1 mg, 31%), which was further purified by
analytical HPLC (hexane–ethyl acetate 85 : 15, flow = 0.8 mL
min−1; tR = 34 min for lactone (Z)-20b, tR = 43 min for linear
dimer 24 and tR = 22 min for 25).
(2R,3S,4S,6S,8Z)-3-Hydroxy-4-(methoxymethoxy)-2,4,6,8-tetra-
methyldec-8-enolide ((Z)-20b). Colourless oil; [α]20D +34.2°
(c 0.1 in CHCl3); IR (film) νmax/cm
−1 3390 (OH), 2925, 1732
(CO), 1458, 1376, 1260, 1028, 721; 1H NMR (400 MHz, CDCl3)
δH 5.50 (1H, ddd, J 7.2, 6.0, 1.5 Hz, 9-H), 5.07 (1H, dd,
J 13.2, 6.0 Hz, 10a-H), 4.77 (1H, d, J 7.2 Hz, CHHOMe), 4.62
(1H, d, J 7.2 Hz, CHHOMe), 4.12 (1H, dd, J 13.2, 7.2 Hz, 10b-
H), 3.72 (1H, d, J 9.6 Hz, 3-H), 3.39 (3H, s, OMe), 2.89 (1H, dq,
J 9.6, 7.2 Hz, 2-H), 2.00 (1H, dd, J 13.2, 1.2 Hz, 7a-H), 1.87 (1H,
dd, J 13.2, 7.8 Hz, 7b-H), 1.80 (3H, t, J 1.5 Hz, 8-Me), 1.72 (2H,
m, 5a-H and 6-H), 1.42 (1H, dd, J 13.2, 7.2 Hz, 5b-H), 1.34 (3H,
s, 4-Me), 1.28 (1H, d, J 7.2 Hz, 2-Me), 1.15 (3H, d, J 6.6 Hz,
6-Me); 13C NMR (100 MHz, CDCl3) δC 173.2, 147.1, 117.1, 90.8,
82.2, 75.0, 59.0, 55.5, 46.0, 42.7, 30.9, 25.5, 25.3, 20.8, 16.5;
HRMS (ESI+): calcd for C16H28O5Na [M + Na]
+ 323.1834, found
323.1839.
Linear dimer 24. Colourless oil; [α]20D −7.3° (c 0.14 in
CHCl3); IR (film) νmax/cm
−1 3454 (OH), 2918, 2850, 1731 (CO),
1646, 1463, 1377, 1163, 757; 1H NMR (400 MHz, CDCl3) δH
5.87 (2H, m, 2′-H), 4.73 (2H, br s, 9a-H), 4.66 (2H, d, J 7.2 Hz,
CHHOMe), 4.64 (2H, br s, 9b-H), 4.63 (2H, d, J 7.2 Hz,
CHHOMe), 4.60–4.54 (4H, m, 1′-H), 3.67 (OH, d, J 9.2 Hz),
3.46 (2H, dd, J 9.2, 2.8 Hz, 3-H), 3.32 (6H, s, OMe), 2.79 (2H,
dq, J 7.2, 2.8 Hz, 2-H), 2.07 (2H, dd, J 12.8, 5.6 Hz, 7a-H),
Paper Organic & Biomolecular Chemistry
















































1.86–1.75 (6H, m, 5a-H, 6-H and 7b-H), 1.68 (6H, s, 8-Me),
1.35–1.30 (2H, m, 5b-H), 1.33 (6H, d, J 7.2 Hz, 2-Me), 1.28 (6H,
s, 4-Me), 0.89 (6H, d, J 6.4 Hz, 6-Me); 13C NMR (100 MHz,
CDCl3) δC 176.1 (2C), 144.5 (2C), 128.1 (2C), 111.8 (2C), 91.0
(2C), 81.4 (2C), 79.1 (2C), 63.9 (2C), 55.6 (2C), 47.8 (2C), 42.9
(2C), 38.9 (2C), 26.6 (2C), 22.1 (2C), 21.4 (2C), 20.6 (2C), 17.1




methoxy)-2,4,6,8-tetramethylnon-8-enoate (25). Colourless oil;
[α]20D −6.1° (c 0.1 in CHCl3); IR (film) νmax/cm−1 3454 (OH),
2920, 2850, 1735 (CO), 1458, 1164, 1032, 966; 1H NMR
(400 MHz, CDCl3) δH 7.38 (2H, m, Harom), 7.32 (2H, m,
Harom), 7.25 (1H, m, Harom), 6.65 (1H, d, J 15.6 Hz, 3′-H),
6.28 (1H, dt, J 15.6, 6.6 Hz, 2′-H), 4.74–4.71 (3H, m, 1′-H), 4.66
(1H, d, J 7.2 Hz, CHHOMe), 4.64 (1H, d, J 7.2 Hz, CHHOMe),
4.62 (1H, br s, 9a-H), 3.75 (OH, d, J 9.2 Hz), 3.48 (1H, dd, J 9.2,
2.8 Hz, 3-H), 3.31 (3H, s, OMe), 2.82 (1H, dq, J 7.2, 2.8 Hz,
2-H), 2.06 (1H, dd, J 13.2, 6.0 Hz, 7a-H), 1.84–1.80 (2H, m,
7a-H and 5a-H), 1.78–1.73 (1H, m, 6-H), 1.67 (3H, s, 6-Me),
1.36 (3H, d, J 7.2 Hz, 2-Me), 1.30 (1H, dd, J 13.8, 7.8 Hz, 5b-H),
1.29 (3H, s, 4-Me), 0.88 (3H, d, J 6.0 Hz, 6-Me); 13C NMR
(100 MHz, CDCl3) δC 176.3, 144.5, 134.4, 130.2, 128.6
(2C), 128.1, 126.6 (2C), 123.0, 111.8, 91.0, 81.4, 79.2, 65.1,
55.6, 47.8, 43.0, 38.8, 26.6, 22.1, 21.3, 20.7, 17.2; HRMS (CI+):
calcd for C24H37O5 [M + H]
+ 405.2488, found 405.2497.
Acetylation of natural product 1/26. Pyridine (2 drops) was
added to a solution of natural product 1 (3.0 mg, 0.01 mmol)
in acetic anhydride (0.5 mL) at 0 °C and stirred at room temp-
erature for 18 h. Then, cyclohexane was added (2 mL) and the
solvent was evaporated under reduced pressure. This pro-
cedure was repeated three times to give quantitatively
(3R,4S,5S,2′R,4′E)-4-acetoxy-5-(6-acetoxy-2,4-dimethylhex-4-enyl)-
3,5-dimethyl-4,5-dihydrofuran-2(3H)-one (26a) (3.4 mg, 100%).
Yellow oil: [α]20D −10.3° (c 0.30, CHCl3); IR (film) νmax 2945,
1775, 1740, 1455, 1374, 1223, 1087, 1022, 990, 939 cm−1;
1H NMR (400 MHz, C6D6) δ 5.36 (t, J = 6.8 Hz, 1H), 4.97 (d, J =
5.8 Hz, 1H), 4.58 (d, J = 6.8 Hz, 2H), 2.32 (dq, J = 6.8, 5.8 Hz,
1H), 2.14 (m, 1H), 1.71 (s, 3H), 1.68–1.61 (m, 3H), 1.59 (s, 3H),
1.48 (s, 3H), 1.26 (dd, J = 14.0, 5.2 Hz, 1H), 0.99 (d, J = 6.8 Hz,
3H), 0.82 (s, 3H), 0.69 (d, J = 6.0 Hz, 3H); 13C NMR (100 MHz,
C6D6) δ 175.2, 170.1, 169.2, 140.2, 121.5, 85.0, 77.0, 61.0, 48.1,
41.0, 38.5, 26.5, 22.6, 21.1, 20.5, 19.8, 16.0, 8.8; HRMS (ESI+):
calcd for C18H28O6Na [M + Na]
+ 363.1784, found 363.1795.
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